BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
TCBK
TriCo Bancshares
TCBK has a slight edge over BAC overall on the model score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
TCBK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
TCBK's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like TCBK.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
TCBK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $43.55 | -16% |
| Fair | 12x | $53.64 | +4% |
| Current | 12x | $51.58 | — |
| Forward | 12x | $51.58 | — |
| Expensive | 14x | $60.04 | +16% |
Historical ranges are pointers, not guarantees.
TCBK has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over TCBK on the outlook, with more favorable valuation expectations.
TCBK Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for TCBK, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over TCBK on earnings, with more consistent year-over-year improvement.
TCBK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.44 | +3.2% |
| Q3 2026 | $4.30 | +21% |
| Q2 2026 | $4.16 | +22% |
| Q1 2026 | $3.94 | +15% |
| Q4 2025 | $3.70 | +6.9% |
| Q3 2025 | $3.56 | +6% |
| Q2 2025 | $3.40 | 0% |
| Q1 2025 | $3.43 | +4.6% |
| Q4 2024 | $3.46 | -1.7% |
TCBK earned $4.30 per share over the past year, up 21% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over TCBK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
TCBK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $116.7M | +8.5% |
| Q2 2026 | $111.9M | +8% |
| Q1 2026 | $108.3M | +9.8% |
| Q4 2025 | $109.4M | +9% |
| Q3 2025 | $107.6M | +8.5% |
| Q2 2025 | $103.6M | +5.9% |
| Q1 2025 | $98.6M | +0.1% |
| Q4 2024 | $100.4M | -2.2% |
TCBK's revenue has grown year over year for seven quarters in a row: $117M last quarter, up 8.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 45% | +1.4 points |
| Q2 2026 | 41% | +4.9 points |
| Q1 2026 | 42% | +6.6 points |
| Q4 2025 | 43% | +3.8 points |
| Q3 2025 | 43% | +3.5 points |
| Q2 2025 | 37% | -3.5 points |
| Q1 2025 | 36% | -2.5 points |
| Q4 2024 | 39% | +3.3 points |
TCBK has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over TCBK on cash flow, with more consistent year-over-year improvement.
TCBK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $39.1M | -9.5% |
| Q2 2026 | $23.2M | -18% |
| Q1 2026 | $33M | +45% |
| Q4 2025 | $33.7M | +47% |
| Q3 2025 | $43.2M | +58% |
| Q2 2025 | $28.2M | -8.5% |
| Q1 2025 | $22.8M | -5.1% |
| Q4 2024 | $22.9M | -35% |
TCBK's free cash flow was $129M over the past year, up 10% from the year before. Free cash flow isn't a meaningful measure for financial services companies like TCBK.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over TCBK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
TCBK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +11K shares |
| 1 year | -1.8% | -605K shares |
| 3 years | -3.6% | -1.2M shares |
| 5 years | +7.6% | +2.3M shares |
| Available history | +4.8% | +1.5M shares |
TCBK has 32M diluted shares, down 1.8% from a year ago, with $34M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $1.8M |
| Q1 2026 | $22.4M |
| Q4 2025 | $9.7M |
| Q3 2025 | $2.5M |
| Q2 2025 | $15.7M |
| Q1 2025 | $4.1M |
| Q4 2024 | $1.9M |
TCBK spent $34M buying back its own shares over the past year, up 40% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
TCBK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -1.6x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -1.4x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
TCBK has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
TCBK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.7 | Neutral |
| Stochastic | 21.0 | Neutral |
TCBK's weekly RSI is 46 (neutral) and its Stochastic is 21 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
TCBK PE vs Financial Services Sector
| Metric | TCBK | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.8% below |
| PE % | 40 | 63 | 23 pts below |
TCBK has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
TCBK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.2 | 1.1% below |
| 20 week MA | $54.4 | 5.1% below |
| 50 week MA | $51.5 | 0.2% above |
| 100 week MA | $46.9 | 10% above |
| 200 week MA | $43.1 | 20% above |
TCBK has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
TCBK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $40.8 | $34.5 | -15% |
| 2021 | $34.5 | $42.0 | +22% |
| 2022 | $42.0 | $50.5 | +20% |
| 2023 | $50.5 | $43.0 | -15% |
| 2024 | $43.0 | $44.0 | +2.5% |
| 2025 | $44.0 | $48.3 | +9.7% |
| 2026 YTD | $48.3 | $51.6 | +6.8% |
TCBK has the edge over BAC on returns for 2026, with the stronger performance.